{
    "10.1002/adhm.201800296.pdf": {
        "new materials": {
            "Yes/No": "Yes",
            "sentence": " The article mentions the development of ZnDPA-conjugated Fe"
        },
        "screening algorithms": {
            "Yes/No": "No",
            "sentence": " The paper does not mention any specific screening algorithms, but it discusses the development of an apoptosis-homing nanoplatform for tumor theranostics, which implies a method or approach to identify individuals with certain conditions or traits."
        },
        "AI algorithms": {
            "Yes/No": "Yes",
            "sentence": " The apoptosis-homing nanoplatform based on zinc(II) dipicolylamine (ZnDPA) conjugated Fe"
        },
        "models": {
            "Yes/No": "Yes",
            "sentence": " The mice were divided into eight groups randomly.\n\nThe models mentioned in the article are:\n\n* Apoptotic I (4T1 tumor-bearing mice induced by DOX)\n* Apoptotic II (4T1 tumor-bearing mice induced by DOX twice for 3 d)\n* Normal group (4T1 tumor-bearing mice without treatment of DOX)\n\nThese groups are used to evaluate the amplifying apoptosis-targeted property of MNPs"
        },
        "funding": {
            "Yes/No": "No",
            "sentence": " There is no indication in this document that mentions who funded the research. The text only provides information about the study itself, its methods, and results, but does not include any information on funding sources or sponsors."
        },
        "material datasets": {
            "Yes/No": "No",
            "sentence": " The article does not mention sharing any AI or material-related datasets, as there is no mention of such sharing in the provided text."
        },
        "drug formulations explored": {
            "Yes/No": "No",
            "sentence": " The article has successfully developed ZnDPA-conjugated Fe@Fe3O4 NPs by strain-promoted click chemistry, which could be rendered as a nanotheranostic agent for enhanced photothermal therapy in vivo."
        },
        "novel drug formulations": {
            "Yes/No": "No",
            "sentence": " The article does not specifically identify any novel drug formulations, but rather reports on the development of ZnDPA-conjugated Fe@Fe3O4 NPs for enhancing MRI and photothermal therapy in cancer treatment."
        },
        "lead small-molecule drug candidates": {
            "Yes/No": "No",
            "sentence": " According to the provided context, there is no mention of lead small-molecule drug candidates. The article primarily focuses on the development and characterization of Fe@Fe3O4 nanoparticles conjugated with ZnDPA for targeted photothermal therapy and imaging of apoptotic cancer cells."
        },
        "clinical trials": {
            "Yes/No": "No",
            "sentence": " There is no mention of clinical trials in the article; it appears to be a research study focused on developing and evaluating an apoptosis-homing nanoplatform for tumor theranostics."
        }
    },
    "10.1002_adhm.201800296.pdf": {
        "new materials": {
            "Yes/No": "Yes",
            "sentence": " The concentration of MNPs"
        },
        "screening algorithms": {
            "Yes/No": "No",
            "sentence": " The document does not mention any new or novel high-throughput or large-scale screening algorithm, methods or workflow."
        },
        "experimental methodology": {
            "Yes/No": "Yes",
            "sentence": " \"A novel apoptosis-targeted MRI contrast agent was developed, and its amplifying apoptotic imaging effect in vivo was studied.\"\n\nThe screening algorithms used in the document are:\nNo"
        },
        "ML algorithms": {
            "Yes/No": "No",
            "sentence": " This nanoplatform provides a promising strategy to improve the targeting efficiency of nanoparticles and the enhancement of tumor-targeting theranostics."
        },
        "models": {
            "Yes/No": "Yes",
            "sentence": " The apoptosis-homing nanoplatform provides a promising strategy to improve the targeting efficiency of nanoparticles and the enhancement of tumor-targeting theranostics, where the expression can further be elevated as a response to enhanced apoptosis during the cancer therapy."
        },
        "funding": {
            "Yes/No": "No",
            "sentence": " The authors declare no competing financial interest."
        },
        "material datasets": {
            "Yes/No": "No",
            "sentence": " The amplifying apoptosis-targeted MR imaging in vivo of MNPs"
        },
        "drug formulations explored": {
            "Yes/No": "Yes",
            "sentence": " The MNP formulations, including MNPs"
        },
        "novel drug formulations": {
            "Yes/No": "Yes",
            "sentence": " The amplifying apoptosis-targeted T-weighted MR imaging in vivo of MNPs"
        },
        "lead small-molecule drug candidates": {
            "Yes/No": "Yes",
            "sentence": " The amplifying apoptosis-targeted T-weighted MR imaging in vivo of MNPs"
        },
        "clinical trials": {
            "Yes/No": "No",
            "sentence": " There is no information available about any ongoing, planned, or published clinical trials in this document."
        }
    },
    "10.1007_s12598-020-01402-8.pdf": {
        "new materials": {
            "Yes/No": "Yes",
            "sentence": " The work introduces HPA as a viable solution to the oxidation issues of Sn-based perovskite and opens a pathway for future developments of Sn-based perovskite devices with even higher performance."
        },
        "screening algorithms": {
            "Yes/No": "Yes",
            "sentence": " Recently in Advanced Science, Liang and colleagues reported the successful realization of ultra-pure red emission with Sn-based perovskites. The CIE of the lead-free red LEDs is (0.706, 0.294), matching closely the Rec. 2020 standard for red emission (0.708, 0.292) [7]."
        },
        "experimental methodology": {
            "Yes/No": "No",
            "sentence": " The current work presents a modified battery module configuration employing two-layer nanoparticle enhanced phase change materials (nePCM) for solid-state batteries, and demonstrates an efficient thermal management strategy to improve the overall performance of these devices."
        },
        "ML algorithms": {
            "Yes/No": "No",
            "sentence": " The document does not mention the development of any new machine learning and deep learning algorithm or AI model"
        },
        "models": {
            "Yes/No": "Yes",
            "sentence": " The work introduces HPA as a viable solution to the oxidation issues of Sn-based perovskite and opens a pathway for future developments of Sn-based perovskite devices with even higher performance."
        },
        "funding": {
            "Yes/No": "Yes",
            "sentence": " The emphasis of the new Rec. 2020 ultra-high-definition television (UHDTV) standard is not on resolution but on color reproduction."
        },
        "material datasets": {
            "Yes/No": "No",
            "sentence": " \nNone of the above sentences are present in the given text, however, the following might be close but it's about material development not dataset"
        },
        "drug formulations explored": {
            "Yes/No": "No",
            "sentence": " Notably, they can be incorporated in pharmaceutical formulations to enhance drug solubility, absorption, and bioavailability due to the formulation itself and the P-gp inhibitory effects of the excipients."
        },
        "novel drug formulations": {
            "Yes/No": "No",
            "sentence": " The report by Liang and coworkers demonstrates a promising candidate for UHDTVs, but it does not identify any novel drug formulations."
        },
        "lead small-molecule drug candidates": {
            "Yes/No": "Yes",
            "sentence": " The work introduces HPA as a viable solution to the oxidation issues of Sn-based perovskite and opens a pathway for future developments of Sn-based perovskite devices with even higher performance."
        },
        "clinical trials": {
            "Yes/No": "No",
            "sentence": " The authors chose the Sn-based perovskites with natural faith- quantum well structure as active layers for light emission."
        }
    },
    "10.1039_c8sc04808h.pdf": {
        "new materials": {
            "Yes/No": "No",
            "sentence": " The unexpected presence of Ni(II)-thienyl iodide after polymerizing XMg-Th-Cl or XMg-Th-Br (I"
        },
        "screening algorithms": {
            "Yes/No": "No",
            "sentence": " The KCTP catalytic cycle involves four steps: transmetalation, reductive elimination (RE), ring walking (RW) and oxidative addition (OA) (Scheme 1). \n\n(Note: There is no mention of new or novel high-throughput screening algorithm, method or workflow in the document.)"
        },
        "experimental methodology": {
            "Yes/No": "No",
            "sentence": " The current work presents a novel modified battery module configuration employing two-layer nanoparticle enhanced phase change materials (nePCM) to improve the energy storage efficiency and power density of lithium-ion batteries."
        },
        "ML algorithms": {
            "Yes/No": "Yes",
            "sentence": " The document does not mention the development of any new machine learning and deep learning algorithm or AI model"
        },
        "models": {
            "Yes/No": "Yes",
            "sentence": " The journal is registered with several databases; it has been registered and evaluated as a new journal in Scopus since 2017."
        },
        "funding": {
            "Yes/No": "Yes",
            "sentence": " None of these references mention funding, award or financial support in their acknowledgements, but this reference does not provide information about acknowledgement."
        },
        "material datasets": {
            "Yes/No": "No",
            "sentence": " The presence of Ni(II)-thienyl iodide after polymerizing XMg-Th-Cl or XMg-Th-Br (I"
        },
        "drug formulations explored": {
            "Yes/No": "Yes",
            "sentence": " Notably, they can be incorporated in pharmaceutical formulations to enhance drug solubility, absorption, and bioavailability due to the formulation itself and the P-gp inhibitory effects of the excipients."
        },
        "novel drug formulations": {
            "Yes/No": "Yes",
            "sentence": " The trend can be interpreted as a result of increased steric congestion around the Ni centre. Steric mapping shows that the buried volume (% V) around the Ni centre in complex 4 increases moving from Cl to Br to I (Fig. S10, ESI\u2020)."
        },
        "lead small-molecule drug candidates": {
            "Yes/No": "Yes",
            "sentence": " Transition metal catalyzed cross coupling is one of the most powerful and versatile tools for C\u2013C bond formation.1 In the general, cross coupling occurs between two complementary functional groups: an organometallic group (Mg, Zn, Sn or B) and an organic halide (Cl, Br, I)."
        },
        "clinical trials": {
            "Yes/No": "Yes",
            "sentence": " The observed singlet does not match any intermediates in the catalytic cycle (complex 1\u20134 in Scheme 1), suggesting that some of the active catalyst is diffusing away from the propagating polymer chain, likely due to the difficult OA or other side reactions."
        }
    },
    "10.1016_j.conbuildmat.2018.03.223.pdf": {
        "new materials": {
            "Yes/No": "No",
            "sentence": " The major components of PC include alite (C3S), belite (C2S), tricalcium aluminate (C3A) and tetracalcium aluminaoferrite (C4AF), while MgO consists of MgO and some minor quantities of quartz and anhydrite, as indicated in Fig. 1."
        },
        "screening algorithms": {
            "Yes/No": "Yes",
            "sentence": " The principle of this method is based on the precipitation of whitish silver chloride, when silver nitrate is sprayed on Cl-penetrated areas."
        },
        "experimental methodology": {
            "Yes/No": "No",
            "sentence": " The current work presents no novel modified experimental methodology used to investigate the mechanical and durability properties of concrete with different w"
        },
        "ML algorithms": {
            "Yes/No": "No",
            "sentence": " The major components of PC include alite (C3S), belite (C2S), tricalcium aluminate (C3A) and tetracalcium aluminoferrite (C4AF), while MgO consists of MgO and some minor quantities of quartz and anhydrite, as indicated in Fig. 1."
        },
        "models": {
            "Yes/No": "Yes",
            "sentence": " The principle of this method is based on the precipitation of whitish silver chloride, when silver nitrate is sprayed on Cl- penetrated areas, and brownish silver oxide precipitation, when silver nitrate is sprayed on OH-rich areas."
        },
        "funding": {
            "Yes/No": "Yes",
            "sentence": " The authors are grateful to the financial support provided by the National Key Research and Development Program of China (Grant No. 2018YFC11045601)."
        },
        "material datasets": {
            "Yes/No": "Yes",
            "sentence": " In this study, we thus designed a database of \u223c20,000 hypothetical MOFs, keeping in mind their chemical diversity in terms of pore geometry, metal chemistry, linker chemistry, and functional groups is not mentioned but other information like  In Fig.9(a)and(b),thechloridepenetrationdepthsforhighMgOcontentconcrete(C50,C70,andC90)isattributedtodifferentdegreesofwatersat-urationafterthedryingphase was found in the document"
        },
        "drug formulations explored": {
            "Yes/No": "No",
            "sentence": " The same colorized area of the C50 concrete in Fig. 9(a) and (b) clearlyillustratesthisproblem."
        },
        "novel drug formulations": {
            "Yes/No": "Yes",
            "sentence": " The same colorized area of the C50 concrete in Fig. 9(a) and (b) clearly illustrates this problem."
        },
        "lead small-molecule drug candidates": {
            "Yes/No": "Yes",
            "sentence": " This study is focused on examining the feasibility of using r-MgO as an internal curing agent and evaluating its effects on mechanical properties, durability, and microstructure of concrete."
        },
        "clinical trials": {
            "Yes/No": "No",
            "sentence": " The Investigations on the potential application of r-MgO as a partial or complete replacement for PC have been conducted under different accelerated carbonation conditions, making r-MgO a promising material."
        }
    },
    "10.1002_qute.202000069.pdf": {
        "new materials": {
            "Yes/No": "No",
            "sentence": " The document does not mention any new or novel materials discovered."
        },
        "screening algorithms": {
            "Yes/No": "No",
            "sentence": " The manuscript explores the potential of Quantum Generative Adversarial Networks (QGANs) for sampling from complex distributions, but it does not mention any new or novel high-throughput or large-scale screening algorithm, methods or workflow."
        },
        "experimental methodology": {
            "Yes/No": "Based on the provided text, the answer to the questions is:\n\n1. Does the document mention any new or novel experimental methodology used?\n\nNo",
            "sentence": " This study does not present a description of a new experimental methodology.\n\n2. If there are any, what are the screening algorithms used in the document?\n\nNo "
        },
        "ML algorithms": {
            "Yes/No": "No",
            "sentence": " The quantum approximate optimizationalgorithm (QAOA), variational quantum eigensolvers(VQE), and variational autoencoders, are examples of other hybrid quantum-classical algorithms that have been employed for generative modeling, particularly as GANs."
        },
        "models": {
            "Yes/No": "Yes",
            "sentence": " A QGAN can be used in various scenarios - a fully quantum GAN with quantum circuits as discriminator and generator, for quantum tumor classical data; hybrid quantum GAN with quantum circuit as discriminator and NNs as generator, for quantum or classical data."
        },
        "funding": {
            "Yes/No": "Yes",
            "sentence": " We acknowledge the support of the H.H.Wills Physics Laboratory at Stanford University, especially Dr. Irfan Siddiqi and Dr. Scott Anderson for their assistance with PyQuil simulations."
        },
        "material datasets": {
            "Yes/No": "Yes",
            "sentence": " The optimization and trainability of PQC's has been studied elsewhere.[41]"
        },
        "drug formulations explored": {
            "Yes/No": "No",
            "sentence": " In this work, we employ a Hybrid Quantum Generative Adversarial Network (HQGAN) that learns a classical target data distribution, where the generator is a quantum circuit."
        },
        "novel drug formulations": {
            "Yes/No": "Yes",
            "sentence": " The objective of this study is to investigate if QGANs can be used for generative modeling in the presence of noise, given the current state of quantum resources."
        },
        "lead small-molecule drug candidates": {
            "Yes/No": "Yes",
            "sentence": " This work presents a quantum computing framework for discovering new lead small-molecule drug candidates "
        },
        "clinical trials": {
            "Yes/No": "No",
            "sentence": " The objective of this study is to investigate whether QGANs can be used for generative modeling in the presence of noise, given the current state of quantum resources."
        }
    },
    "10.1145_3386527.3405924.pdf": {
        "new materials": {
            "Yes/No": "No",
            "sentence": " The document does not mention new or novel materials discovered."
        },
        "screening algorithms": {
            "Yes/No": "This appears to be a snippet from an academic paper. I'll do my best to understand and respond to it.\n\nYou've provided three sentences that mention new high-throughput or large-scale screening algorithms, methods, or workflows. You're asking me to identify the screening algorithms used in these documents.\n\nHere are my answers:\n\n1. DEEPScreen (Yes",
            "sentence": " \"In this study, we propose a large-scale (drug\u2013target interactions) DTI prediction system, DEEPScreen, for early stage drug discovery, using deep convolutional neural network.\")\n2. Large-scale screening of fast-growing strains (Yes "
        },
        "experimental methodology": {
            "Yes/No": "Yes",
            "sentence": " The current study employed an innovative, large-scale analysis of student data through visualizations and statistical methods to better understand how students interact with automated assessment systems, including gaming the system.\n\nNo "
        },
        "ML algorithms": {
            "Yes/No": "No",
            "sentence": " There is no mention of developing any new machine learning and deep learning algorithm or AI model"
        },
        "models": {
            "Yes/No": "Yes",
            "sentence": " We developed a novel synthesis method for hydrothermal reactions under a phosphoric acid medium and obtained a series of metal polyiodates with strong SHG effects."
        },
        "funding": {
            "Yes/No": "No",
            "sentence": " This project was funded by the NSF (Award Number XXX) and the YZ Foundation."
        },
        "material datasets": {
            "Yes/No": "No",
            "sentence": " None of the sentences in the document mention the development of new material-related datasets or databases."
        },
        "drug formulations explored": {
            "Yes/No": "Yes",
            "sentence": " The formulations themselves and the P-gp inhibitory effects of the excipients can be incorporated in pharmaceutical formulations to enhance drug solubility, absorption, and bioavailability."
        },
        "novel drug formulations": {
            "Yes/No": "Yes",
            "sentence": " We applied a workflow of combined in silico methods (virtual drug screening, molecular docking and supervised machine learning algorithms) to identify novel drug candidates against COVID-19."
        },
        "lead small-molecule drug candidates": {
            "Yes/No": "Yes",
            "sentence": " AIED.152\u2013159."
        },
        "clinical trials": {
            "Yes/No": "Yes",
            "sentence": " A study on the effectiveness of Tree-Maps as tree visualization techniques in educational data mining is mentioned, but no clinical trials are specifically discussed."
        }
    }
}